GW Pharma Reports Success with THC and CBD Combo in Brain Cancer Phase 2 Clinical Trial
GW Pharmaceuticals Achieves Positive Results in Phase 2 Proof of Concept Study in Glioma GW intends to advance oncology research and development efforts LONDON, Feb. 07, 2017 (GLOBE NEWSWIRE)...